Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas

This publication has 23 references indexed in Scilit:

• Restored expression of transforming growth factor β type II receptor ink-ras-transformed thyroid cells, TGFβ-resistant, reverts their malignant phenotype
  Journal of Cellular Physiology, 1997
• Abnormal expression of CCNDI and RBI in resection margin epithelia of lung cancer patients
  British Journal of Cancer, 1997
• Status and expression of thep16INK4 gene in human thyroid tumors and thyroid-tumor cell lines
  International Journal of Cancer, 1996
• Abundance and subcellular localisation of cyclin D3 in human tumours
  International Journal of Cancer, 1996
• Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
  Advances in Cancer Research, 1996
• Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1
  Human Pathology, 1995
• Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
  Cell, 1994
• Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.
  Proceedings of the National Academy of Sciences, 1993
• Induction of the c- fos Oncogene by Thyrotropic Hormone in Rat Thyroid Cells in Culture
  Science, 1986
• Dissociation between transformed and differentiated phenotype in rat thyroid epithelial cells after transformation with a temperature-sensitive mutant of the Kirsten murine sarcoma virus.
  Molecular and Cellular Biology, 1983